Related Experiment Videos
Evaluation of spindle cell tumors.
1Department of Laboratory Medicine, University of Minnesota School of Medicine, Minneapolis.
Clinics in Dermatology
|April 1, 1991
Summary
Clinical examination and immunohistochemistry are crucial for diagnosing skin and soft tissue spindle cell tumors when histology is inconclusive. Immunohistochemistry accurately identifies the tumor type in over 90% of challenging cases.
Area of Science:
- Dermatopathology
- Oncology
- Surgical Pathology
Background:
- Spindle cell tumors of the skin and superficial soft tissues present diagnostic challenges.
- Clinical examination provides valuable initial information regarding tumor location, appearance, and size.
- Histologic features can be distinctive, but are sometimes insufficient for definitive diagnosis.
Purpose of the Study:
- To evaluate the utility of immunohistochemistry in diagnosing challenging spindle cell tumors.
- To compare immunohistochemistry with other diagnostic modalities like electron microscopy.
- To highlight common diagnostic dilemmas and their resolution.
Main Methods:
- Review of clinical and histopathologic findings in cases of spindle cell tumors.
- Application of immunohistochemistry to histologically ambiguous lesions.
- Comparison of diagnostic outcomes using clinical, histologic, and immunohistochemical data.
Main Results:
- Immunohistochemistry successfully determined the immunophenotype in at least 90% of histologically enigmatic tumors.
- Electron microscopy, while promising, has limitations in tissue availability and accessibility.
- Diagnostic challenges include differentiating malignant peripheral nerve sheath tumors (MPNST) from leiomyosarcomas (LMS) and identifying melanocytic lesions.
Conclusions:
- Immunohistochemistry is the preferred method for diagnosing problematic spindle cell tumors.
- Accurate tissue preservation is vital for reliable immunohistochemical results.
- Further research is needed, particularly for distinguishing melanocytic lesions from peripheral nerve sheath tumors.